Physician profile
Thomas Ray Cartwright
NPI 1740277466
$860.17
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $122 · 2021: $400 · 2022: $51.99.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $289.15 | 2019-2021 | |
| Inspire Medical Systems, INC. | $117.36 | 2021 | |
| Mylan Specialty L.P. | $52.71 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $42.75 | 2021 | |
| Allergan, INC. | $32.91 | 2020 | |
| Pfizer INC. | $32.76 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.38 | 2019-2021 | |
| Amgen INC. | $29.18 | 2019 | |
| Gilead Sciences, INC. | $28.67 | 2021 | |
| United Therapeutics Corporation | $20.24 | 2021 | |
| Paratek Pharmaceuticals, INC. | $19.54 | 2021 | |
| Avanir Pharmaceuticals, INC. | $19.53 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.23 | 2022 | |
| Resmed Corp | $18.70 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $15.35 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $14.94 | 2021 | |
| Fisher & Paykel Healthcare INC | $13.98 | 2020 | |
| Janssen Biotech, INC. | $13.30 | 2020 | |
| Acorda Therapeutics, INC | $13.24 | 2019 | |
| Csl Behring | $12.95 | 2019 | |
| Jazz Pharmaceuticals INC. | $12.06 | 2019 | |
| Genzyme Corporation | $11.24 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Cartwright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.